Sign in / Join Now
ETFs & Funds
As far as
, they have a huge problem with Jakafi. For details, look at youtube video by Dr. Pardanani, who is @ Mayo.
Jakafi is a terrible drug for MF and should not have been approved by the FDA. This makes other indications for Jakafi very questionable.
Add a reply...
Latest StockTalks »
people get INCY breaking news and analysis by email alert.
Get email alerts on INCY »
Get latest price
From other sites
Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended
at Zacks.com (Mon, 7:39AM)
Incyte/Merck to Start More Epacadostat-Keytruda Studies
at Zacks.com (Jan 10, 2017)
NewLink pops after Incyte and Merck announce IDO inhibitor pact
at TalkMarkets (Jan 9, 2017)
Merck Cancer Drug Test Sends Incyte Shares Higher
at TheStreet (Jan 9, 2017)
Incyte Reaches Analyst Target Price
at Nasdaq.com (Jan 9, 2017)